Skip to main content
. Author manuscript; available in PMC: 2015 Sep 8.
Published in final edited form as: Nanotechnol Rev. 2012 Mar;1(2):111–146. doi: 10.1515/ntrev-2011-0005

Figure 16.

Figure 16

Schematic illustration of active targeting of nanoparticles. Tumor targeting ligands such as antibodies, peptides, aptamers, folate, and hyaluronic can be attached to the PS-containing nanoparticle, frequently by means of linkers such as PEG.